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ABSTRACT 
Stepped wedge cluster randomized controlled trials (RCTs) are increasingly used in evaluating a 
causal-effect relationship between an intervention and an outcome. Sample size and power 
calculations are critical in designing a statistical study. Thus, the purpose of our study is to 
evaluate the power for both the continuous and binary responses in the context of the stepped 
wedge cluster design including three levels (such as hospital, physician, and individual levels). 
The data structure of stepped wedge cluster RCTs is hierarchical and correlated, and we used 
the mixed models approach to account for the correlation of observations within each level. This 
approach, comprised of linear mixed models (LMM) and generalized linear mixed models 
(GLMM), is particularly appropriate for data with more than one level. For the continuous 
responses, we used LMM and GLMM with the identity link function; for the binary responses, 
we used GLMM with the logit link function. To compute the power of the hypothesis test for no 
intervention effect versus an assumed intervention effect, simulation studies were conducted and 
the empirical estimate of the power was obtained by calculating the percentage of the estimated 
intervention effect falling in the rejection region of the test when the hypothesis of no 
intervention effect is false. 
 v 
From the results of the simulation studies, we found that the power increased as the 
intervention effect increased for both the continuous and binary responses, controlling for other 
parameters. As the overall sample size increased, a smaller minimum detectable difference with 
power at least 80% can be obtained. For the continuous responses only, the power increased as 
the within-individual correlation increased, controlling for other parameters. This increase of 
power with the correlation was prominent in the low intervention effect as compared to the high 
intervention effect.  
In this study, we proposed statistical models, demonstrated power calculations, and discussed 
important features of sample size and power for the stepped wedge cluster design. The findings 
provide essential information in determining the optimal sample size and also can assure 
adequate power for stepped wedge cluster RCTs, which will have significant impact on research 
in public health in the future. 
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1.0  INTRODUCTION 
Randomized controlled trials (RCTs) are considered as the “gold standard” of study designs in 
evaluating a causal-effect of an intervention on the outcome of interest [1]. Through a 
randomization procedure using RCTs, one can prevent bias in allocating interventions and 
reduce confounding caused by observed and unobserved factors [2]. Cluster RCTs are a type of 
RCTs in which clusters of individuals, rather than independent individuals, are randomly 
allocated to intervention or control groups. Advantages of cluster RCTs over individual RCTs 
include the capability of studying those interventions which can only be administered in groups 
(e.g., promotion of lifestyle changes through radio broadcasting) and the capability of avoiding 
contamination between those with and without interventions (e.g., individuals who receive 
interventions may affect those who receive no interventions via communications) [3]. Because in 
the cluster design individuals are more similar within a cluster than between clusters, the 
correlation (or dependence) within the same cluster should be incorporated into the analysis to 
avoid making incorrect inferences [4]. 
Stepped wedge cluster RCTs employ a one-direction crossover design in which every cluster 
receives the control at baseline and then sequentially initiates the intervention at different time 
points. The order at which each cluster initiates the intervention is determined at random before 
the start of the trial. Figure 1 illustrates an example of a stepped wedge cluster RCT including 
five time points (i.e., four randomization steps). Every cluster receives the control at the first 
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time point, and cluster 1 is randomly allocated to initiate the intervention at the second time 
point, and so on. At the last time point, all clusters will receive the intervention. More than one 
cluster may initiate the intervention at a time point. Once a cluster initiates the intervention, it 
will be on the intervention until the end of the trial. Data are collected longitudinally at each time 
point. The effect of the intervention can be evaluated by comparing the data collected at the time 
points in the intervention section with those in the control section. Brown et al. [5] and Mdege et 
al. [6] have provided articles of systematic review on this approach. 
The advantages of choosing stepped wedge cluster RCTs over parallel or crossover cluster 
RCTs have been addressed in the literature. First, fewer ethical issues will arise when using 
stepped wedge cluster RCTs. The parallel or crossover designs require equipoise, a status of 
genuine uncertainty of whether the intervention is superior to the control [7]. If there exists a 
prior belief that the intervention will bring more benefits than harm, it may be unethical to 
withdraw the intervention (such as crossover design) or to allocate the control (such as parallel 
design) [8]. Stepped wedge cluster RCTs can solve this ethical dilemma because all clusters will 
eventually receive the intervention [5, 6, 9-12]. Second, stepped wedge cluster RCTs are useful if 
the intervention can only be implemented in stages because of logical, practical, and financial 
constraints [5, 12-15]. For example, the effect of a school-based anti-smoking campaign can be 
evaluated by a stepped wedge cluster RCT because there is only one team of trained educators 
traveling to each school and delivering the prevention curriculum in turn. Third, stepped wedge 
cluster RCTs may require fewer clusters because each cluster will receive both the intervention 
and the control, whereas in parallel cluster RCTs each cluster will receive either the intervention 
or the control [16]. Fourth, compared to parallel cluster RCTs where the analysis involves 
between-cluster comparisons only, stepped wedge cluster RCTs have higher statistical power 
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because both within-cluster comparisons and between-cluster comparisons are considered in the 
analysis [17]. 
Stepped wedge cluster RCTs also have some limitations that warrant consideration. First, 
stepped wedge cluster RCTs may require longer trial duration than parallel cluster RCTs because 
it will take several steps to complete a stepped wedge cluster RCT [5, 6, 16]. If the primary 
outcome can be detected soon after clusters initiate the intervention, the total duration of stepped 
wedge cluster RCTs is likely to be acceptable. If it takes a long time for the primary outcome to 
occur, stepped wedge cluster RCTs may not be easily implemented because of a long total 
duration [6]. Second, it is almost impossible to blind the participants and those who administer 
the intervention because both would be aware of the changes from the control to the intervention 
in a stepped wedge cluster design. Thus, blinding those who assess the outcome becomes 
important in preventing information bias, in particular when the outcome is subjective [5, 6]. 
Third, stepped wedge cluster RCTs require that data are collected at each step where a new 
cluster initiates the intervention. If data collection is not easy or not done on a routine basis, the 
cost for implementation may be substantial [6, 18]. 
Power calculations and simulations of stepped wedge cluster RCTs have been demonstrated 
by Hussey et al [16]. Both a cluster-level model (addressing the responses as the mean of each 
cluster) and an individual-level model were proposed to characterize the design and analysis of 
stepped wedge cluster RCTs. The authors compared the three approaches: linear mixed models 
(LMM), generalized linear mixed models (GLMM), and generalized estimating equations 
(GEE). LMM can be used when the responses were continuous and normally distributed. It may 
also be used in the situation where the individual-level responses were not normal (e.g., binary) 
and the cluster sizes were equal, because the cluster-level responses (e.g., proportion) can then be 
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modeled as continuous variables. However, if the individual-level responses were not normal but 
the cluster sizes were unequal, LMM may not be useful because the analysis at the cluster level 
would require weights. In this situation, using GLMM or GEE to directly model the individual-
level responses will be preferable. The GLMM, an extension to LMM, can be used to model 
normal and non-normal responses via a link function. More specifically, the mean of responses 
with any distribution in the exponential family can be linked to the linear predictors through a 
link function. Using GEE as an alternative approach, one can handle normal and non-normal 
responses with flexibility. It can also provide more robust results when there is an issue of 
misspecification of the variance structure.  
However, Hussey et al. presented the models which addressed the stepped wedge cluster 
design with only two levels (i.e., cluster and individual levels). This may not be applicable to the 
general setting of a clinical research where three levels (i.e., hospital, physician, and individual 
levels) exist; in other words, where individuals’ repeated measures are nested within a physician 
who is nested within a hospital. Additionally, the power calculations and simulations in their 
studies were for the binary responses. The purpose of the current study is to evaluate the power 
for the continuous responses and the binary responses in the context of the stepped wedge cluster 
design with hospital, physician, and individual levels. 
In Section 2, we propose the models for the continuous responses and the binary responses, 
and present the methods of power calculations. In Section 3, we carry out a set of simulation 
studies to demonstrate the methods shown in Section 2. In Section 4, we describe an example 
which uses the stepped wedge cluster design with market, dialysis center, and patient levels, and 
then apply our methods of power calculations to the example. In Section 5, we summarize our 
results and discuss the aspects of future studies. 
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2.0  METHODS 
2.1 MODELS 
The data structure of stepped wedge cluster RCTs is hierarchical (i.e., multi-level). As shown in 
Figure 1 as an example of study design, the repeated measures are nested within an individual 
who is nested within a cluster. Because of the nature of hierarchy, the data of stepped wedge 
cluster RCTs are correlated; in other words, the repeated measures are more similar within an 
individual than between individuals, and the individuals are more similar within a cluster than 
between clusters. The mixed models approach is widely used for hierarchical data to account for 
the dependence of observations within the same level. By adding random variation in the model, 
mixed models provide a more convenient approach to handle the dependence of observations and 
also allow us to make inferences on a wider population. Compared to generalized estimating 
equations (GEE), mixed models are particularly appropriate to be used on data with more than 
one level. For the current study, we specifically adopt the random effects models (also known as 
random intercept models) to control for the dependence within each level. 
Mixed models are comprised of linear mixed models (LMM) and generalized linear mixed 
models (GLMM). LMM is used to analyze data with a normal distribution; GLMM is used to 
analyze data with any distribution of the exponential family (e.g., normal, Bernoulli, and Poisson 
distributions). GLMM is an extension to LMM, and utilizes a certain link functions to map the 
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responses from the observational scale (e.g., 0 and 1 for the binary responses) to the real scale (-
∞, +∞). In other words, the mean of responses with any distribution of the exponential family are 
transformed by a link function so that it can be related to the linear predictors. LMM is a special 
case of GLMM in which the distribution of responses is assumed to be normal and the identity 
link function is applied to relate the mean of responses to the linear predictors. In Sections 2.1.1 
and 2.1.2, we will introduce the statistical models of the continuous responses and the binary 
responses for a stepped wedge cluster design. The model of the binary responses is shown as an 
example of the GLMM models because it is the most frequent situation where data are not 
normal. Similar results can be derived for other types of data using GLMM. 
In the current study, individuals are nested within a physician who is nested within a hospital.  
We assume that in a stepped wedge cluster design we roll out I hospitals over J time points, and 
for each hospital there are K physicians, and for each physician we recruit L individuals. Let 
random variable Yijkl represent the response for individual l (l = 1, …, L) at time j (j = 1, …, J) 
and the individual is recruited from physician k (k = 1, …, K) at hospital i (i = 1, …, I). The 
hospital is considered as the unit of randomization (i.e., cluster); that is, all individuals in the 
same hospital will initiate the intervention at the same time point. 
2.1.1 Model of the continuous responses 
Suppose that Yijkl is a continuous response and assumed to be normally distributed, the model is 
presented as follows:  
 Yijkl = μ + αi + βik + tj + Xijθ + eijkl, ( 1 ) 
where μ is the grand mean; αi is the random effect of hospital i such that αi ∼ N (0, τ
2); βik is the 
random effect of physician k nested within hospital i and βik ∼ N (0, φ
2
); tj is the fixed effect of 
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time j; Xij is the indicator of intervention for hospital i at time j (Xij = 1 for intervention; Xij = 0 
for control); θ is the fixed effect of intervention; and eijkl is the residual error such that eikl = [ei1kl, 
ei2kl, …, eiJkl]
T
 ∼ NJ (0, Σ) and Σ =  
2[
   
   
   
]
   
. We also assume that αi and βik are 
independent of each other in addition to being independent of tj, Xij, and eijkl. In this model, αi 
and βik provide the hospital- and physician- specific intercepts, which can be thought of as 
natural heterogeneity due to unmeasured factors between hospitals and between physicians, 
respectively. Besides, αi can be used to account for the dependence between physicians in each 
hospital, and βik can be used to account for the dependence between individuals for each 
physician. The dependence between repeated measures for each individual is explained by the 
residual error, eijkl. 
2.1.2 Model of the binary responses 
Suppose that Yijkl is a binary response (taking values of 0 or 1), the model is presented as 
follows:  
log {
            
            
} = μ + αi + βik + γikl + tj + Xijθ. ( 2 ) 
That is, the mean of the responses is related to the linear predictors through a logit link function. 
Most parameters are the same as we describe for model ( 1 ) except that γikl is added and the 
residual error is removed. γikl is the random effect of individual l that is nested within physician k 
and hospital i such that γikl ∼ N (0, ζ
2
). Instead of using the residual error to control the 
dependence of repeated measures for each individual in model ( 1 ), an individual-specific 
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random intercept is included in model ( 2 ) to account for natural heterogeneity between 
individuals and handle the dependence of repeated measures within an individual.  
2.2 POWER CALCULATIONS 
The power of a statistical test is the probability that the test rejects the null hypothesis when the 
null hypothesis is false. That is, 
Power = Prob (reject the null hypothesis | the null hypothesis is false). 
Thus, we first specify a significance level (known as type I error, α), and then determine the 
rejection region for which the null probability in the rejection region achieves α. Based on this 
rejection region, the power can be obtained from the alternative probability in the rejection 
region. For the current study, the goal is to test the hypothesis H0: θ = 0 (no intervention effect) 
versus Ha: θ = θA where θA ≠ 0 for both model ( 1 ) and model ( 2 ) using the stepped wedge 
cluster design with I hospitals, J time points, K physicians under each hospital, and L individuals 
under each physician. After receiving  ̂ from LMM and/or GLMM approaches, we use the 
distribution of the Wald statistic Z =  ̂ /√     ̂  to obtain the empirical estimate of the power by 
computing the percentage of  ̂ falling in the rejection region when the null hypothesis is false. 
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3.0  SIMULATION STUDIES 
We carried out a set of simulation studies to assess the power of the hypothesis test H0: θ = 0 
versus Ha: θ = θA where θA ≠ 0. At each of repetitions, the simulated dataset consisted of 12 
hospitals (I = 12), 5 time points (J = 5), 5 physicians under each hospital (K = 5), and 50 
individuals under each physician (L=50). Because the hospital was the unit of randomization, all 
hospitals started with the control at the first time point (j = 1) and then every 3 hospitals switched 
to the intervention at each randomization step. Then, the simulated datasets were modeled using 
LMM with function lme() and/or GLMM with function glmmPQL() in R version 2.14.1. In 
addition, the performance of the simulation studies was evaluated using three measures: 95% 
coverage rate of the true θ, empirical standard error of  ̂ (i.e., SE( ̂)), and the mean of standard 
error of  ̂ (i.e.,   ̂  ̂ ). For the current simulation studies, we set the parameters based on the 
stepped wedge cluster design from Hussey et al. [16], and extended the design to the one with 
three levels. Other specifications can also be applied as we will describe in Section 4. 
3.1 SIMULATION RESULTS OF THE CONTINUOUS RESPONSES 
The continuous longitudinal profile was generated based on model ( 1 ) with between-hospital 
variance τ2 = 0.01 and between-physician variance φ2 = 0.5. The residual error was specified as 
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compound symmetry with variance σ2 = 1 and correlation ρ = 0.2 - 0.9. The grand mean μ was 
fixed as 0.5 and the intervention effect θ was -0.03, -0.05, and -0.07. We assumed no time effect, 
tj = 0. The level of significance was specified as α = 0.05. Then, the dataset was modeled using 
both LMM and GLMM with the identity link function. Each scenario was simulated with 1,000 
repetitions. 
Table 1 and Figure 2 summarize the results of the simulation studies for the continuous 
responses. The results from LMM and GLMM with the identity link function are similar to each 
other. When the intervention effect is -0.03 and the correlation is 0.9, the power is 0.894; when 
the intervention effect is -0.05 and the correlation is 0.7, the power is 0.872-0.873; when the 
intervention effect is -0.07 and the correlation is 0.3-0.4, the power is 0.811-0.868. That is, to 
achieve power 0.8-0.9, observations with the intervention, compared to those without the 
intervention, have lower responses by 0.03 when the correlation is 0.9; by 0.05 when the 
correlation is 0.7; by 0.07 when the correlation is 0.3-0.4. This shows that when the intervention 
effect is fixed, the power increases as the correlation increases. This increase of power with the 
correlation is steeper in the low intervention effect (e.g., θ = -0.03) as compared to the high 
intervention effect (e.g., θ = -0.07). When the correlation is fixed, the power increases as the 
intervention effect (absolute value of θ) increases. In all scenarios, the coverage rates 
approximate the nominal 95%, and SE( ̂) and   ̂  ̂  are close to each other. This evidence 
validates the simulation results of the continuous responses. 
 11 
3.2 SIMULATION RESULTS OF THE BINARY RESPONSES 
The binary longitudinal profile was generated based on model ( 2 ) with between-hospital 
variance τ2 = 0.01, between-physician variance φ2 = 0.05, and between-individual variance ζ2 = 
0.1. Under the logit link function, the grand mean μ was fixed as 0.5 and the intervention effect θ 
was varied between -0.10 and -0.20. We assumed no time effect, tj = 0. The level of significance 
was specified as α = 0.05. Then, the dataset was modeled using GLMM with the logit link 
function. Each scenario was simulated with 2,000 repetitions. 
Table 2 and Figure 3 summarize the results of the simulation studies for the binary responses. 
The results show that the power is 0.864 when the intervention effect is -0.18 under the logit link 
function (corresponding to the odds ratio = exp(-0.18) = 0.84). That is, when the power is 0.864, 
the odds of the responses decrease 16% for those with the intervention compared to those 
without the intervention. As we expected, the power increases as the intervention effect (absolute 
value of θ) increases. In all scenarios, the coverage rates are close to the nominal 95%, and SE( ̂) 
and   ̂  ̂  are similar to each other. Thus, we can conclude that the simulation results of the 
binary responses are appropriate. 
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4.0  APPLICATIONS 
Hospice care is underused in end-stage renal disease (ESRD) patients on dialysis. Among annual 
65,000 deaths of ESRD patients on dialysis in the United States, only 20% of them receive 
hospice care in the last month of life, which is remarkably lower than patients with cancer (55%) 
and patients with congestive heart failure (39%) [19]. Because of the underuse of hospice care in 
ESRD patients on dialysis, three-quarters of them die with distressing symptoms and half of 
them are admitted to an intensive care unit at the end of life [20, 21]. This situation is due to the 
current Medicare payment policy which structurally separates ESRD benefits (i.e., dialysis) from 
hospice benefits. More specifically, patients who have a terminal diagnosis as ESRD are required 
to withdraw from dialysis in order to receive hospice care. Since withdrawal from dialysis for 
ESRD patients leads to death in 4 days for 50% of patients [22], most ESRD patients decide to 
continue dialysis, rather than receive hospice care but withdraw from dialysis. 
To address this situation, the Center for Research on Health Care at the University of 
Pittsburgh School of Medicine proposed concurrent supportive care for ESRD patients on 
dialysis. In collaboration with dialysis and hospice providers, ESRD patients will concurrently 
receive dialysis and hospice care, and a payment model will be developed to cover the expenses 
by employing a capped bundled payment with shared provider risks and saving to control costs. 
The goal of concurrent supportive care was to increase advance care planning, enhance hospice 
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use, improve qualify of dying, and reduce total Medicare costs mainly through decreasing acute 
care utilization.  
A stepped wedge cluster design was planned for evaluating the effect of concurrent 
supportive care in ESRD patients on dialysis. Corresponding to Section 2, hospital-physician-
individual relation was equivalent to market-dialysis center-patient relation in this application. 
That is, the patients were nested within a dialysis center which was nested within a market. For a 
stepped wedge cluster design, we planned to have about 250 patients in 12 markets (I = 12) 
nationwide over 7 time points (J = 7), and every 2 markets will initiate to receive concurrent 
supportive care at each randomization step. In each market, there will be 6 dialysis centers (K = 
6). Two designs were considered and compared; one with total patients fewer than 250 and one 
with total patients more than 250. In comparison, Design 1 included 12 markets (I = 12), 6 
dialysis centers within each market (K = 6), and 3 patients within each dialysis center (L = 3) 
(i.e., 216 patients in total), whereas Design 2 included 12 markets (I = 12), 6 dialysis centers 
within each market (K = 6), and 4 patients within each dialysis center (L = 4) (i.e., 288 patients 
in total).  The major difference between the two designs was the number of patients within each 
dialysis center. 
Similar to Section 3, a set of simulation studies was conducted to assess the power of the 
hypothesis test for the effect of concurrent supportive care, H0: θ = 0 versus Ha: θ = θA where θA 
≠ 0. In fact, the main purpose was to determine the minimum detectable difference for the effect 
of concurrent supportive care in order to reach at least 80% power. We implemented LMM with 
function lme() and/or GLMM with function glmmPQL() in R. Besides, 95% coverage rate of the 
true θ, empirical standard error of  ̂ (i.e., SE( ̂)), and the mean of standard error of  ̂ (i.e.,   ̂  ̂ ) 
were used to evaluate the results of the simulation studies. 
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4.1 APPLICATION RESULTS OF THE CONTINUOUS RESPONSES 
The continuous responses in this application were 1) Medicare costs, and 2) Consumer 
Assessment and Reports of End-of-life Care (CARE) score, which is a measurement of quality of 
dying. For ease of interpretation, all the parameters were standardized as mean = 0 and variance 
= 1, and thus the effect of concurrent supportive care θ can be expressed as the averaged change 
in the continuous responses of one standard deviation above and below the mean, comparing 
those with and without concurrent supportive care. Accordingly, based on model ( 1 ) between-
market variance τ2 and between-dialysis center variance φ2 were standardized as 1. The residual 
error was assumed to be compound symmetry with standardized variance σ2 = 1 and correlation 
ρ = 0.1, 0.3, 0.5 based on preliminary results. The grand mean μ was standardized as 0. We 
assumed no time effect, tj = 0. Varied effects of concurrent supportive care θ were used to find 
the situation with power ≥ 80%. The level of significance was specified as α = 0.05. Analyses 
were conducted using both LMM and GLMM with the identity link function. Each scenario was 
simulated with 1,000 repetitions.  
Table 3 and Table 4 present the simulation results of the continuous responses for Design 1 
and Design 2, respectively. In both designs, the results from LMM and GLMM with the identity 
link function are similar to each other. In Design 1, to achieve power ≥ 80%, the minimum 
detectable difference of one standard deviation above and below the mean is 0.26 (absolute value 
of θ) when the correlation is 0.1; 0.22, when the correlation is 0.3; 0.20, when the correlation is 
0.5. In Design 2, the minimum detectable difference of one standard deviation above and below 
the mean with power ≥ 80% is 0.22, when the correlation is 0.1; 0.20, when the correlation is 
0.3; 0.16, when the correlation is 0.5. Comparing the results from Design 1 (smaller overall 
sample size) with those from Design 2 (larger overall sample size), we can expect that the greater 
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the overall sample size, the smaller the minimum detectable difference. In addition, the coverage 
rates approximate the nominal 95%, and SE( ̂) and   ̂  ̂  are close to each other in all scenarios. 
Thus, the simulation results of the continuous responses are validated. 
4.2 APPLICATION RESULTS OF THE BINARY RESPONSES 
The binary responses in this application were 1) advance care plan (Y/N), and 2) hospice 
enrollment (Y/N). Similar to the continuous responses, the setting of the parameters was 
standardized as mean = 0 and variance = 1. Based on model ( 2 ), between-market variance τ2, 
between-dialysis center variance φ2, and between-patient variance ζ2 were standardized as 1. 
Under the logit link function, the grand mean μ was standardized as 0. We assumed no time 
effect, tj = 0. We studied several effects of concurrent supportive care θ in order to find the 
situations in which power ≥ 80%. The level of significance was specified as α = 0.05. Analysis 
was conducted using GLMM with the logit link function. Each scenario was simulated with 
2,000 repetitions.  
Table 5 and Table 6 show the simulation results of the binary responses for Design 1 and 
Design 2, respectively. In Design 1, to achieve power ≥ 80%, the minimum detectable difference 
for the effect of concurrent supportive care is 0.60 (absolute value of θ) under the logit link 
function, which can be expressed as an odds ratio of exp(θ) = exp(-0.60) = 0.55. In Design 2, the 
minimum detectable difference for the effect of concurrent supportive care with power ≥ 80% is 
0.52 under the logit link function, corresponding to an odds ratio of exp(θ) = exp(-0.52) = 0.59. 
Like the continuous responses, as the overall sample size increases from Design 1 to Design 2, 
we can detect a smaller difference between those with and without concurrent supportive care 
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when power ≥ 80%. The coverage rates are around 0.92, which is slightly smaller than 0.95. To 
further improve the coverage rates, a possible solution is to use a better estimator for SE  ̂ . 
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5.0  DISCUSSION 
For a stepped wedge cluster RCT with three levels (e.g., an individual is nested within a 
physician who is nested within a hospital), we proposed statistical models for the continuous 
responses and the binary responses, and computed the power for testing the intervention effect 
using simulation studies. For a continuous outcome response, parameters required to calculate 
the power included the sample size of each level, the number of time points (or randomization 
steps), between-hospital variance, between-physician variance, residual variance (such as 
correlation structure, variance, and correlation), grand mean of the responses, intervention effect, 
and time effect. For a binary outcome response, parameters required to calculate the power 
included the sample size of each level, the number of time points (or randomization steps), 
between-hospital variance, between-physician variance, between-individual variance, percent 
responses for the population, intervention effect, and time effect. We also found that the power 
increased as the intervention effect increased for both the continuous and binary responses, 
controlling for other parameters. Besides, as the overall sample size increased, a smaller 
minimum detectable difference with a sufficient power can be achieved. For the continuous 
responses only, the power increased as the within-individual correlation increased, controlling 
for other parameters. This increase of power with the correlation was prominent in the low 
intervention effect as compared to the high intervention effect.  
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We assumed an equal sample size for each level in the present study; that is, there were an 
equal number of individuals within every physician and an equal number of physicians within 
every hospital. In addition, we also assumed that an equal number of hospitals started to receive 
the intervention at every randomization step. Although this setting with equal sample size for 
each level would enhance the statistical power [16], this may bring about some restrictions on the 
study design of a stepped wedge cluster RCT. For example, each physician was required to 
recruit 50 individuals in Section 3, and thus a physician who recruited only 40 individuals was 
not eligible to participate in the study. Therefore, relaxing the assumption of equal sample size 
for each level would introduce flexibility in the study design, and power calculations for the 
situation with varied sample sizes for each level are necessary in future research.  
Stepped wedge cluster RCTs are increasingly used in a variety of areas, such as 
cardiovascular diseases [23, 24], nutrition [12, 25], respiratory diseases [14], maternal and child 
health [26, 27], and cancers [13, 28]. Sample size and power calculations are critical in designing 
a trial. However, the available research regarding sample size and power for stepped wedge 
cluster RCTs [16] did not include three levels like a general clinical research (i.e., hospital, 
physician, and individual levels), and did not discuss power calculations and simulations for the 
continuous responses. Therefore, our study is unique and provides essential information to 
determine optimal sample size and assure adequate power for a stepped wedge cluster RCT. 
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APPENDIX: TABLES AND FIGURES 
Table 1. Simulation results for the continuous responses to assess the power of the hypothesis test 
H0: θ = 0 vs. Ha: θ = θA where θA ≠ 0
*
 
 Using LMM Using GLMM with the identity link function 
θ ρ Power SE( ̂)   ̂  ̂  
95% 
coverage 
rate 
Power SE( ̂)   ̂  ̂  
95% 
coverage 
rate 
-0.03 0.2 0.198 0.0266624 0.0266110 0.949 0.198 0.0266643 0.0266031 0.948 
 0.3 0.216 0.0249608 0.0248981 0.949 0.216 0.0249624 0.0248910 0.949 
 0.4 0.247 0.0231128 0.0230563 0.950 0.245 0.0231141 0.0230500 0.949 
 0.5 0.287 0.0210593 0.0210527 0.951 0.288 0.0210603 0.0210471 0.951 
 0.6 0.349 0.0188270 0.0188344 0.951 0.349 0.0188278 0.0188296 0.951 
 0.7 0.454 0.0163377 0.0163147 0.951 0.454 0.0163382 0.0163108 0.950 
 0.8 0.614 0.0133531 0.0133243 0.949 0.614 0.0133534 0.0133212 0.949 
 0.9 0.894 0.0094431 0.0094239 0.949 0.894 0.0094432 0.0094218 0.949 
-0.05 0.2 0.470 0.0266999 0.0266112 0.949 0.470 0.0267017 0.0266033 0.948 
 0.3 0.512 0.0249608 0.0248981 0.949 0.513 0.0249624 0.0248910 0.949 
 0.4 0.570 0.0231080 0.0230564 0.950 0.570 0.0231093 0.0230501 0.949 
 0.5 0.663 0.0210535 0.0210520 0.950 0.662 0.0210545 0.0210465 0.950 
 0.6 0.775 0.0188346 0.0188340 0.951 0.777 0.0188353 0.0188293 0.951 
 0.7 0.873 0.0163351 0.0163147 0.951 0.872 0.0163356 0.0163108 0.950 
 0.8 0.960 0.0133681 0.0133245 0.949 0.960 0.0133685 0.0133215 0.949 
 0.9 0.999 0.0094232 0.0094238 0.949 0.999 0.0094233 0.0094218 0.949 
-0.07 0.2 0.771 0.0266624 0.0266110 0.949 0.771 0.0266643 0.0266031 0.948 
 0.3 0.811 0.0249603 0.0248981 0.949 0.812 0.0249619 0.0248910 0.949 
 0.4 0.868 0.0231204 0.0230563 0.950 0.868 0.0231216 0.0230500 0.949 
 0.5 0.916 0.0210613 0.0210524 0.951 0.916 0.0210623 0.0210468 0.951 
 0.6 0.960 0.0188523 0.0188346 0.951 0.960 0.0188531 0.0188298 0.951 
 0.7 0.991 0.0163221 0.0163149 0.951 0.991 0.0163226 0.0163110 0.950 
 0.8 0.999 0.0133463 0.0133243 0.949 0.999 0.0133466 0.0133212 0.949 
 0.9 1.000 0.0094345 0.0094238 0.949 1.000 0.0094346 0.0094217 0.949 
*
We assumed a stepped wedge cluster design with 12 hospitals, 5 time points, 5 physicians under each hospital, and 50 
individuals under each physician. Based on model ( 1 ), the parameters were fixed as τ2 = 0.01, φ2 = 0.5, μ = 0.5, and tj 
= 0 (no time effect). The residual error was specified as compound symmetry with σ2 = 1 and varied ρ. Type I error 
was set as 0.05. Each scenario was simulated with 1,000 repetitions.  
Abbreviations: LMM, linear mixed models; GLMM, generalized linear mixed models; τ2, between-hospital variance; 
φ2, between-physician variance; σ2, residual variance; ρ, correlation; μ, grand mean; θ, intervention effect; tj, time 
effect. 
 20 
Table 2. Simulation results for the binary responses to assess the power of the hypothesis test H0: θ = 0 
vs. Ha: θ = θA where θA ≠ 0
* 
 Using GLMM with the logit link function 
θ Odds ratio† Power SE( ̂)   ̂  ̂  
95% 
coverage 
rate 
-0.10 0.90 0.396 0.0581411 0.0573366 0.948 
-0.12 0.89 0.525 0.0576691 0.0572949 0.954 
-0.14 0.87 0.658 0.0580020 0.0572549 0.946 
-0.16 0.85 0.770 0.0578155 0.0572142 0.950 
-0.18 0.84 0.864 0.0578998 0.0571781 0.945 
-0.20 0.82 0.926 0.0578106 0.0571418 0.945 
*
We assumed a stepped wedge cluster design with 12 hospitals, 5 time points, 5 
physicians under each hospital, and 50 individuals under each physician. 
Based on model ( 2 ), the parameters were fixed as τ2 = 0.01, φ2 = 0.05, ζ2 = 
0.1, μ = 0.5, and tj = 0 (no time effect). Type I error was set as 0.05. Each 
scenario was simulated with 2,000 repetitions.  
†Effect size can be expressed as odds ratio, which is exp(θ). 
Abbreviations: GLMM, generalized linear mixed models; τ2, between-hospital 
variance; φ2, between-physician variance; ζ2, between-individual variance; μ, 
grand mean; θ, intervention effect; tj, time effect.
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Table 3. Application of the continuous responses for a stepped wedge cluster design with 12 markets, 7 
time points, 6 dialysis centers under each market, and 3 patients under each dialysis center to assess the 
power of the hypothesis test H0: θ = 0 vs. Ha: θ = θA where θA ≠ 0
* 
 Using LMM Using GLMM with the identity link function 
θ ρ Power SE( ̂)   ̂  ̂  
95% 
coverage 
rate 
Power SE( ̂)   ̂  ̂  
95% 
coverage 
rate 
-0.24 0.1 0.789 0.0856657 0.0863325 0.953 0.791 0.0856874 0.0860788 0.953 
-0.26  0.840 0.0856030 0.0863342 0.953 0.840 0.0856232 0.0860805 0.953 
-0.28  0.898 0.0856056 0.0863341 0.953 0.901 0.0856268 0.0860804 0.953 
-0.30  0.949 0.0856030 0.0863342 0.953 0.949 0.0856232 0.0860805 0.953 
-0.20 0.3 0.735 0.0754826 0.0761870 0.953 0.735 0.0754985 0.0759671 0.952 
-0.22  0.819 0.0754256 0.0761874 0.953 0.820 0.0754400 0.0759676 0.952 
-0.24  0.877 0.0755268 0.0761905 0.953 0.878 0.0755411 0.0759707 0.952 
-0.26  0.940 0.0754256 0.0761874 0.953 0.940 0.0754400 0.0759676 0.952 
-0.18 0.5 0.793 0.0638411 0.0644316 0.955 0.796 0.0638503 0.0642491 0.953 
-0.20  0.865 0.0638429 0.0644302 0.955 0.866 0.0638521 0.0642477 0.953 
-0.22  0.940 0.0638241 0.0644318 0.955 0.940 0.0638330 0.0642493 0.953 
*
Based on model ( 1 ), the parameters were standardized as τ2 = 1, φ2 = 1, μ = 0, and tj = 0 (no time effect). The residual 
error was specified as compound symmetry with σ2 = 1 and varied ρ. Type I error was set as 0.05. Each scenario was 
simulated with 1,000 repetitions. 
Abbreviations: LMM, linear mixed models; GLMM, generalized linear mixed models; τ2, between-market variance; φ2, 
between-dialysis center variance; σ2, residual variance; ρ, correlation; μ, grand mean; θ, effect of concurrent supportive 
care; tj, time effect. 
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Table 4. Application of the continuous responses for a stepped wedge cluster design with 12 markets, 7 
time points, 6 dialysis centers under each market, and 4 patients under each dialysis center to assess the 
power of the hypothesis test H0: θ = 0 vs. Ha: θ = θA where θA ≠ 0
* 
 Using LMM Using GLMM with the identity link function 
θ ρ Power SE( ̂)   ̂  ̂  
95% 
coverage 
rate 
Power SE( ̂)   ̂  ̂  
95% 
coverage 
rate 
-0.20 0.1 0.777 0.0747652 0.0748367 0.947 0.779 0.0747727 0.0746718 0.947 
-0.22  0.848 0.0747652 0.0748367 0.947 0.848 0.0747727 0.0746718 0.947 
-0.24  0.902 0.0747652 0.0748367 0.947 0.904 0.0747727 0.0746718 0.947 
-0.18 0.3 0.793 0.0659512 0.0660304 0.947 0.793 0.0659562 0.0658876 0.947 
-0.20  0.865 0.0659512 0.0660304 0.947 0.864 0.0659562 0.0658876 0.947 
-0.22  0.921 0.0659512 0.0660304 0.947 0.921 0.0659562 0.0658876 0.947 
-0.14 0.5 0.724 0.0557517 0.0558315 0.947 0.725 0.0557546 0.0557129 0.947 
-0.16  0.827 0.0557517 0.0558315 0.947 0.830 0.0557546 0.0557129 0.947 
-0.18  0.908 0.0557517 0.0558315 0.947 0.909 0.0557546 0.0557129 0.947 
*
Based on model ( 1 ), the parameters were standardized as τ2 = 1, φ2 = 1, μ = 0, and tj = 0 (no time effect). The residual 
error was specified as compound symmetry with σ2 = 1 and varied ρ. Type I error was set as 0.05. Each scenario was 
simulated with 1,000 repetitions. 
Abbreviations: LMM, linear mixed models; GLMM, generalized linear mixed models; τ2, between-market variance; φ2, 
between-dialysis center variance; σ2, residual variance; ρ, correlation; μ, grand mean; θ, effect of concurrent supportive 
care; tj, time effect. 
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Table 5. Application of the binary responses for a stepped wedge cluster design with 12 markets, 7 time 
points, 6 dialysis centers under each market, and 3 patients under each dialysis center to assess the power 
of the hypothesis test H0: θ = 0 vs. Ha: θ = θA where θA ≠ 0
* 
  Using GLMM with the logit link function 
θ Odds ratio† Power SE(θ̂)   ̂ θ̂  
95% 
coverage 
rate 
-0.58 0.56 0.779 0.2170503 0.1936428 0.918 
-0.60 0.55 0.802 0.2162086 0.1937347 0.921 
-0.62 0.54 0.828 0.2150595 0.1938322 0.927 
-0.64 0.53 0.850 0.2148441 0.1939434 0.923 
-0.66 0.52 0.872 0.2148470 0.1940510 0.919 
-0.68 0.51 0.888 0.2151393 0.1941631 0.922 
-0.70 0.50 0.898 0.2155592 0.1942769 0.918 
-0.72 0.49 0.913 0.2145534 0.1943834 0.915 
*
Based on model ( 2 ), the parameters were standardized as τ2 = 1, φ2 = 1, ζ2 = 
1, μ = 0, and tj = 0 (no time effect). Type I error was set as 0.05. Each scenario 
was simulated with 2,000 repetitions.
 
†Effect size can be expressed as odds ratio, which is exp(θ). 
Abbreviations: GLMM, generalized linear mixed models; τ2, between-market 
variance; φ2, between-dialysis center variance; ζ2, between-patient variance; μ, 
grand mean; θ, effect of concurrent supportive care; tj, time effect. 
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Table 6. Application of the binary responses for a stepped wedge cluster design with 12 markets, 7 time 
points, 6 dialysis centers under each market, and 4 patients under each dialysis center to assess the power 
of the hypothesis test H0: θ = 0 vs. Ha: θ = θA where θA ≠ 0
* 
 Using GLMM with the logit link function 
θ Odds ratio† Power SE(θ̂)   ̂ θ̂  
95%  
coverage  
rate 
-0.50 0.61 0.785 0.1843711 0.1682908 0.919 
-0.52 0.59 0.812 0.1853929 0.1683681 0.918 
-0.54 0.58 0.836 0.1852366 0.1684518 0.918 
-0.56 0.57 0.860 0.1854834 0.1685291 0.913 
-0.58 0.56 0.884 0.1851372 0.1686089 0.916 
-0.60 0.55 0.901 0.1853810 0.1686902 0.918 
*
Based on model ( 2 ), the parameters were standardized as τ2 = 1, φ2 = 1, ζ2 = 
1, μ = 0, and tj = 0 (no time effect). Type I error was set as 0.05. Each 
scenario was simulated with 2,000 repetitions.
 
†Effect size can be expressed as odds ratio, which is exp(θ).  
Abbreviations: GLMM, generalized linear mixed models; τ2, between-market 
variance; φ2, between-dialysis center variance; ζ2, between-patient variance; μ, 
grand mean; θ, effect of concurrent supportive care; tj, time effect. 
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“0” represents control periods; “1” represents intervention periods. 
Figure 1. Illustration of a stepped wedge cluster design 
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Abbreviations: LMM, linear mixed models; GLMM, generalized linear mixed models; θ, intervention 
effect; ρ, correlation 
Figure 2. Simulation results for the continuous responses
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Abbreviations: GLMM, generalized linear mixed models; θ, intervention effect 
Figure 3. Simulation results for the binary responses to assess the power of the hypothesis test H0: θ = 0 
vs. Ha: θ = θA where θA ≠ 0  
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